CSL HAS ENTERED AGREEMENTS WITH THE U.S. GOVERNMENT TO LOWER DRUG PRICES AND SUPPORT INVESTMENT IN U.S. MANUFACTURING, REFLECTING ITS $1.5 BLN PLAN TO EXPAND U.S. MANUFACTURING CAPACITY IN ILLINOIS, INCLUDING AN ONSHORING AGREEMENT WITH THE U.S. DEPARTMENT OF COMMERCE EXPECTED TO CREATE AT LEAST 300 NEW PHARMACEUTICAL MANUFACTURING JOBS AND APPROXIMATELY 800 CONSTRUCTION AND RELATED JOBS.